Medicine adherence and Star ratings
According to the Centers for Disease Control and Prevention (CDC), the direct cost of medicine non-adherence is estimated at $100 billion to $289 billion annually. Improving medication adherence is critical to patients, health care providers, health insurers, pharmacy and other stakeholders, because increased adherence equates to improved outcomes.
Medicare contracted health plans are evaluated annually by the Centers for Medicare and Medicaid Services (CMS) through the Five-Star quality ratings system to measure their performance. Medicare-contracted health plans are given a star rating (1 to 5 stars) – one star representing low performance, and five stars representing excellent performance.
Read the white paper on star ratings and understand how payers and pharmacists are developing strategies to improve medication adherence.
- Developing a deep understanding of the member population
- Analyzing clinical needs, behaviors and barriers to adherence
- Developing tools and resources to monitor patients’ adherence behavior and clinical outcomes
- Creating collaborative platforms among payers, health care providers, pharmacists and members
- Utilizing patient education materials to help patients understand their disease, their treatment and the negative impact of non-adherence
Complete the form below to read the full whitepaper:
About Clinical Solutions
Elsevier empowers healthcare providers and educates patients, driving the delivery of high quality, economically sound care through world-class clinical content integrated within clinical workflow and EHR systems.